Paul J. Kingma

1.5k total citations · 1 hit paper
8 papers, 553 citations indexed

About

Paul J. Kingma is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Paul J. Kingma has authored 8 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Paul J. Kingma's work include Inflammatory Bowel Disease (4 papers), Liver Diseases and Immunity (2 papers) and Microscopic Colitis (2 papers). Paul J. Kingma is often cited by papers focused on Inflammatory Bowel Disease (4 papers), Liver Diseases and Immunity (2 papers) and Microscopic Colitis (2 papers). Paul J. Kingma collaborates with scholars based in Netherlands and United States. Paul J. Kingma's co-authors include Cyriel Y. Ponsioen, Kirsten Boonstra, A.H.J. Naber, Nan van Geloven, Hans A.R.E. Tuynman, Ben Witteman, Alexander C. Poen, Karel J. van Erpecum, Ulrich Beuers and Joost P.H. Drenth and has published in prestigious journals such as Gastroenterology, Hepatology and Liver International.

In The Last Decade

Paul J. Kingma

8 papers receiving 546 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

2013 472 citations Kirsten Boonstra, Rinse K. Weersma et al. Hepatology profile →

Peers

Countries citing papers authored by Paul J. Kingma

Since Specialization

Citations

This map shows the geographic impact of Paul J. Kingma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Kingma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Kingma more than expected).

Fields of papers citing papers by Paul J. Kingma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Kingma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Kingma. The network helps show where Paul J. Kingma may publish in the future.

Co-authorship network of co-authors of Paul J. Kingma

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Kingma. A scholar is included among the top collaborators of Paul J. Kingma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Kingma. Paul J. Kingma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands 2016 ·European Journal of Gastroenterology & Hepatology ·E. Joline de Groof, Noortje Rossen, Bram D. van Rhijn, (unknown), Kirsten Boonstra, (unknown), Floor Bennebroek Evertsz, Paul J. Kingma, A.H.J. Naber, (unknown), Rosalie C. Mallant–Hent, Marco W. Mundt, Geert D’Haens, Cyriel Y. Ponsioen	46
2	Su1313 Epidemiology and Characteristics of Inflammatory Bowel Disease in a Large Population-Based Cohort in the Netherlands 2015 ·Gastroenterology ·E. Joline de Groof, Noortje Rossen, Bram D. van Rhijn, (unknown), Kirsten Boonstra, (unknown), Paul J. Kingma, A.H.J. Naber, (unknown), Rosalie C. Mallant–Hent, Marco W. Mundt, Geert D’Haens, Cyriel Y. Ponsioen	1
3	Risk factors for primary sclerosing cholangitis 2015 ·Liver International ·Kirsten Boonstra, Elisabeth M. G. de Vries, Nan van Geloven, Karel J. van Erpecum, Marcel Spanier, Alexander C. Poen, (unknown), Ben Witteman, Hans A.R.E. Tuynman, A.H.J. Naber, Paul J. Kingma, Ulrich Beuers, Cyriel Y. Ponsioen, (unknown)	20
4	Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis breakdown → 2013 ·Hepatology ·Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Erik A. Rauws, B.W.M. Spanier, Alexander C. Poen, (unknown), Joost P.H. Drenth, Ben Witteman, Hans A.R.E. Tuynman, A.H.J. Naber, Paul J. Kingma, Henk R. van Buuren, Bart van Hoek, Frank P. Vleggaar, Nan van Geloven, Ulrich Beuers, Cyriel Y. Ponsioen, (unknown)	472
5	Tu1286 Epidemiology and Characteristics of Inflammatory Bowel Disease in a Large Population-Based Cohort in Central Netherlands 2012 ·Gastroenterology ·Noortje Rossen, Bram D. van Rhijn, (unknown), Kirsten Boonstra, Paul J. Kingma, A.H.J. Naber, (unknown), Cyriel Y. Ponsioen	1
6	[Patient with haemolytic uremic syndrome and Escherichia coli (EHEC) infection]. 2011 ·PubMed ·(unknown), (unknown), Leendert J. Bakker, Paul J. Kingma, Laila E. Gamadia, S. Lobatto	2
7	Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus. 1994 ·PubMed ·(unknown), Paul J. Kingma, Bruce H. R. Wolffenbuttel, P. P. C. A. Menheere, (unknown), A. C. Nieuwenhuijzen Kruseman	9
8	Calcium entry blockers and their effects on glucose metabolism. 1990 ·PubMed ·Paul J. Kingma, (unknown), A. C. Nieuwenhuijzen Kruseman, Bruce H. R. Wolffenbuttel	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact